PFIZER INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo
- First Posted Date
- 2006-08-18
- Last Posted Date
- 2009-03-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT00365924
- Locations
- 🇦🇷
Pfizer Investigational Site, Capital Federal - Buenos Aires, Argentina
Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B
Phase 3
Completed
- Conditions
- Hemophilia B
- Interventions
- Drug: Recombinant Coagulation Factor IX (BeneFIX)
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2011-10-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 50
- Registration Number
- NCT00364182
- Locations
- 🇪🇸
Pfizer Investigational Site, Sevilla, Spain
A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
Phase 3
Completed
- Conditions
- Pneumonia, Community-Acquired
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2008-05-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 153
- Registration Number
- NCT00360295
- Locations
- 🇯🇵
Pfizer Investigational Site, Yamagata, Japan
A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
Phase 3
Completed
- Conditions
- Acute Bronchitis
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2011-04-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 64
- Registration Number
- NCT00360464
- Locations
- 🇯🇵
Pfizer Investigational Site, Yonezawa, Yamagata, Japan
A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections
Phase 4
Completed
- Conditions
- Infection
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2008-12-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 307
- Registration Number
- NCT00360607
- Locations
- 🇮🇳
Pfizer Investigational Site, Mumbai, India
Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media
Phase 3
Completed
- Conditions
- Otitis Media
- First Posted Date
- 2006-08-03
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 120
- Registration Number
- NCT00360100
- Locations
- 🇵🇦
Pfizer Investigational Site, Ciudad de Panama, Panama
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Phase 3
Terminated
- Conditions
- Optic Nerve Diseases
- Interventions
- Drug: Matched control
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2015-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 34
- Registration Number
- NCT00359632
- Locations
- 🇺🇸
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
🇺🇸Triple O Research Institute, PA, West Palm Beach, Florida, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety
Phase 4
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1976
- Registration Number
- NCT00359801
- Locations
- 🇬🇧
Pfizer Investigational Site, Westbury, United Kingdom
Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.
Completed
- Conditions
- Heart Valve Diseases
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2007-09-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT00359489
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
Phase 2
Completed
- Conditions
- Pain
- First Posted Date
- 2006-07-28
- Last Posted Date
- 2013-05-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 246
- Registration Number
- NCT00357825
- Locations
- 🇺🇸
Pfizer Investigational Site, Milwaukee, Wisconsin, United States
© Copyright 2025. All Rights Reserved by MedPath